Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

November 22, 2026

Study Completion Date

November 22, 2026

Conditions
Smoking, Tobacco
Interventions
DRUG

2-[18F]-FA PET/CT

2-\[18F\]FA is a highly specific radiotracer which has been used successfully to image nicotinic acetylcholine receptors in the human brain to characterize the effects of nicotine exposure (via smoking) on these receptors.

DRUG

I.V. Nicotine

Subjects in our study will receive intravenous nicotine at the adaptation session and each of the PET scans, close to the amount of nicotine absorbed from smoking 1/10 cigarette.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER